ARL6IP4, also known as ADP-Ribosylation Factor-Like 6 Interacting Protein 4, is involved in the regulation of intracellular trafficking and cellular membrane remodeling. The protein is associated with the Golgi apparatus and endosomal system, which are critical for the proper sorting and delivery of lipids and proteins throughout the cell. This involvement suggests that ARL6IP4 plays a role in maintaining the structural integrity and functional organization of cellular organelles, which is essential for overall cellular health and homeostasis. Additionally, ARL6IP4 is thought to be involved in the process of apoptosis through its interactions with various signaling molecules that regulate cell death pathways, indicating its potential importance in both normal cellular turnover and response to cellular stress or damage.
The inhibition of ARL6IP4 can disrupt normal cellular functions, particularly affecting the processes of intracellular trafficking, membrane organization, and apoptosis. One potential mechanism of inhibition is the direct interference with the protein's ability to interact with other molecular components of the trafficking machinery. This could be mediated by competitive binding of other molecules that mimic the structural or functional domains of ARL6IP4, effectively blocking its interaction with target proteins or lipids. Such inhibition could lead to disorganization within the Golgi and endosomal systems, resulting in improper protein and lipid distribution which could compromise cell viability and function. Another mechanism of inhibition involves transcriptional and post-transcriptional regulation where the expression of ARL6IP4 is reduced due to either transcription factor repression or mRNA destabilization. Additionally, post-translational modifications such as phosphorylation or ubiquitination might alter ARL6IP4's stability or localization, further diminishing its functional capacity in the cell. These inhibitory effects on ARL6IP4 could have significant implications, leading to cellular dysfunction and increased susceptibility to stress and apoptotic signals. Understanding these mechanisms is crucial for comprehending the role of ARL6IP4 in cellular maintenance and integrity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
This compound can elevate intracellular calcium levels by inhibiting ER calcium ATPases. Elevated calcium can disrupt ER functions and may influence ARL6IP4-associated processes. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation in the ER, affecting protein processing and potentially influencing ARL6IP4's functions. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $114.00 $203.00 $354.00 $697.00 $1363.00 $5836.00 | 12 | |
This compound disrupts ER-associated degradation, potentially affecting proteins related to ARL6IP4. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that might impact the degradation of proteins associated with ARL6IP4 pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
This calcium ionophore can elevate intracellular calcium, affecting ER functions that may be associated with ARL6IP4. | ||||||
Saracatinib | 379231-04-6 | sc-364607 sc-364607A | 10 mg 200 mg | $115.00 $1056.00 | 7 | |
Inhibitor of Src family kinases, potentially affecting signaling pathways related to ARL6IP4. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Inhibits dephosphorylation of eIF2α and affects ER stress, which may indirectly impact ARL6IP4 functions. | ||||||